Financial News
Articles published by Oragenics, Inc.
Oragenics, Inc. Files 10K and Provides Company Update
April 01, 2024
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics Announces Closing of Public Offering
March 01, 2024
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics Announces Pricing of Public Offering
February 27, 2024
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics Announces Proposed Public Offering
February 27, 2024
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics, Inc. Announces Leadership Transition
February 12, 2024
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement
February 07, 2024
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics Announces Termination of At-The-Market Offering Program
January 23, 2024
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics Announces Appointment of Bruce Cassidy and John Gandolfo to Board of Directors
October 18, 2023
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics Enters into Agreement with Lantern Bioworks for Replacement-Therapy Assets
September 29, 2023
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics, Inc. Announces Private Placement
August 07, 2023
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics Announces Positive Results in Several Lantibiotics Compounds Against MRSA and VRE
March 14, 2023
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics Appoints Janet Huffman as Chief Financial Officer Strengthening Executive Leadership Team
March 08, 2023
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics, Inc. Regains Compliance with NYSE American
February 03, 2023
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics, Inc. Discloses One-for-Sixty Reverse Stock Split
December 23, 2022
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics Reports Favorable Toxicology Results for its COVID-19 Intranasal Vaccine Candidate
December 22, 2022
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics, Inc. Receives NYSE American Notice
December 20, 2022
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics, Inc. Announces New Chair
December 19, 2022
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics to Participate in the 2022 BioFlorida Annual Conference
October 24, 2022
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics Issues Letter to Shareholders
September 30, 2022
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics Announces Favorable Preliminary Toxicology Data for Intranasal COVID-19 Vaccine Candidate
August 24, 2022
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer
June 23, 2022
From Oragenics, Inc.
Via Business Wire
Tickers
OGEN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.